{ Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland.

Slides:



Advertisements
Similar presentations
Positive Implications of Initiating Insulin Pump Therapy at Diagnosis of Type 1 Diabetes Ramchandani, Neesha 1 ; Ten, Svetlana 1 ; Anhalt, Henry 2 ; Sinha,
Advertisements

Diabetes in Young Women Francine R. Kaufman, M.D. Professor of Pediatrics The Keck School of Medicine of USC Head, Center for Diabetes and Endocrinology.
Insulin Therapy. Insulin Treatment (when?) Any Glucose Level Age Rapid onset Weight loss Tablets fail Pregnancy Illness Ketoacidosis Pancreat-ectomy.
Advanced Pumping. Objectives: Identify situations to utilize temporary basal rate in pump therapy patients. Identify examples of when to use combination.
Insulin Diabetes Outreach (June 2011). 2 Insulin Learning outcomes >Understand the difference between insulin therapy in type 1 diabetes as compared to.
Canadian Diabetes Assocaition Clinical Practice Guidelines Pharmacotherapy in Type 1 Diabetes Chapter 12 Angela McGibbon, Cindy Richardson, Cheri Hernandez,
DIABETES MEDICATION UPDATE A. Sami Wood, MS, RD/LD,CDE Center For Diabetes Education OSUMC.
Insulin initiation OPTIMISING Glycaemic control and Weight Dr C Rajeswaran Consultant Physician Diabetes & Endocrinology Mid Yorkshire NHS Trust.
Insulin Pump What to tell your patient!! Prakash Abraham Isla Fairley.
Putting Pump Policies Into Practice- Case Study Conference Call Elizabeth Blair, ANP-BC,CDE Joyce Lekarcyk, RN, CDE.
Diabetes Control in Youth: The American Experience Georgeanna J. Klingensmith, MD Keystone Colorado July 2008.
INPATIENT DIABETES GUIDE Ananda Nimalasuriya M.D..
Clinical Protocol Using Insulin Pump Easy Guideline for Initiating Insulin Pumps on Type 2 Diabetes Patients.
Insulin therapy.
Insulin Prescribing.
INSULIN THERAPY IN TYPE 1 DIABETES
PRE-EXISTING DIABETES AND PREGNANCY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Diabetes Technology Update
Clinical Update in Type 2 Diabetes A Case Discussion Dr. Yancey R. Holmes, MD, FACE Ohio Valley Endocrinology.
Bradford Insulin Pump Service Gill Atherton Sandra Dudding Diabetes Specialist Nurses.
Journal Club 2009 年 1 月 29 日(木) 8 : 20 ~ 8 : 50 B 棟 8 階カンファレンスルーム 薬剤部 TTSP 石井 英俊.
Who should access pump therapy? UK perspective Dr Thomas Ulahannan International Diabetes Federation European Region General Assembly Together We Are Stronger.
Journal Club 埼玉医科大学 総合医療センター 内分泌・糖尿病内科 Department of Endocrinology and Diabetes, Saitama Medical Center, Saitama Medical University 松田 昌文 Matsuda, Masafumi.
Diabetes: What’s New? What’s Next? Robert P. Hoffman, M.D. Grand Rounds June 1, 2007.
Basal Bolus: The Strategy for Managing All Diabetes Fall, 2003 Paul Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
Toujeo® and it’s Place in Therapy
دکتر رحیم وکیلی استاد غدد ومتابولیسم کودکان دانشگاه علوم پزشکی مشهد INSULIN THERAY IN TYPE 1 DIABETES.
Endocrine and Metabolic Disorders Lectures 8 I.Kuziv, MD, PhD.
Type I Diabetes Mellitus
Identify barriers to effective patient teaching. Identify and teach to the standards of medical care for the management of Type 2 diabetes Describe the.
INSULIN PUMPS Shelby Polk DNP, FNP-BC, CDE. 2 MANAGEMENT OF DIABETES IN SCHOOLS Exercise Legal Rights Health & Learning Nutrition Insulin Administration.
Elizabeth DeRobertis, MS, RD, CDN, CDE, CPT Director of The Nutrition Center, Scarsdale Medical Group
Tresiba- insulin degludec
Insulin Initiation With NovoMix30
Diabetes Update: Michael Gottschalk, M.D, Ph.D.
Endocrine System KNH 411. Diabetes Mellitus 7% of population; 1/3 undiagnosed $132 billion in health care Sixth leading cause of death Complications of.
Insulin initiation in Type 2 Diabetes
What Key Personal Need To Know INSULIN ADMINISTRATION.
Insulin Optimisation Workshop Theingi Aung & Claire Rowell.
Special Situations In The Management Of In-Patient Hyperglycemia
Lesson One Cabin/ Archery Station (Vocabulary). Doctor’s Video What is Type-1 Diabetes What causes Type-1 Diabetes What are the symptoms How is it diagnosed.
Changes in the concentration of serum C-peptide in type 2 diabetes during long-term continuous subcutaneous insulin infusion therapy Department of Internal.
Introduction Subcutaneous insulin absorption is not reproducible and insulin entry directly into the circulation is not linked to glucose sensing Basal.
To Pump OR To Inject … that is the Question … ?
Achieving Optimal Glycaemic Control: Can Insulin Deliver?
Key publication slides
Diabetic hypoglycemia from prevention to management.
Key publication slides
Insulin Delivery Systems Atlanta Diabetes Associates
Copyright © 2004 American Medical Association. All rights reserved.
Comparison of Basal insulins, Initiation and titration of Lantus
Karen McAvoy RN, MSN, CDE Joslin Diabetes Center
Endocrine System KNH 411.
Insulin Pump Therapy – A Shared Journey
Endocrine System KNH 411.
Injectable Therapies in Diabetes
Insulin Safety know your insulins! There are many! Humalog® Mix25 Humalog® Mix50 Humulin® I Humulin® M3 Humulin® S Humalog® U-100 Humalog® U-200.
T1DM: Insulin Initiation
New Patient-Friendly Options for Managing Insulin Dosing
Continuous Subcutaneous Insulin Infusion (CSII) [Insulin Pump]
Novel Concentrated Insulins: What Benefits and for Which Patients?
Endocrine System KNH 411.
Faster-Acting Insulins
Treatment Pathway for Adults with Type 1 Diabetes
Younger Patients With Type 1 Diabetes: Can We Optimize Their Insulin Therapy?
Approach to starting and adjusting insulin in type 2 diabetes.
Endocrine System KNH 411.
Endocrine System KNH 411.
INSULINS Dr.R.Sajjad december INSULINS Dr.R.Sajjad december 2018.
Fresh perspectives ON BASAL Insulins in diabetes care
Presentation transcript:

{ Practicalities of intesive insulin therapy to optimase diabetes control Ewa Pańkowska MD, PhD Warsaw, Poland Warsaw, Poland

 At least four injections per day  At least four glucose measurements per day. Outcomes:  Less microvascular complications  More severe hypoglycemia events Intensive Insulin Therapy DCCT, NEJM, years ago…

{ as a first choice regime for persons with type 1 diabetes Flexible, Intensive Insulin Therapy FIIT ISPAD recommendation, ADA recommendation, PDA recommendation 10 years ago…

British Medical Journal; 2002; Conclusion: Skills training promoting dietary freedom improved quality of life and glycaemic control in people with type 1 diabetes without worsening hypoglycemia

What FIIT means? Tsukuda, K. DT&T, 2009

{ The tools and the algorythm in FIIT Multiple daily injection vs continuous subcutaneous insulin infusion

1. There are a lot of evidences that CSII improves metabolic control (HbA1c) comparing to MDI method. Is that True or False? 2. Insulin pump therapy significantly decreases risk of severe hypoglycemia events. True or False? questions:

The comparison between MDI and CSII. Are there relevant differences for metabolic control

Pańkowska, E, ADA 2011 P<0,05 Basal insulin IU/kg/d Total daily dose IU/kg/d MDI CSII Parallel day – to – day study

 Mealtime insulin Regular insulin Regular insulin Rapid acting analogue Rapid acting analogue  Basal insulin: NPH NPH Long acting analogue Long acting analogue  Delivering insulin: subcutaneous and shots administartion subcutaneous and shots administartion  Mealtime insulin Rapid acting analogue Rapid acting analogue  Basal insulin: Rapid acting analogue Rapid acting analogue  Delivering insulin: Subcutaneus and continuous administartion Subcutaneus and continuous administartion * NPH – Isophane insulin (intermediate-acting)

 Number of injection/month average: average:  Insulin depot in subcutaneous tissue basal insulin dose - 20 IU basal insulin dose - 20 IU  Logbook as a form of injected insulin dose registration  Number of injection/month average: 8-10 average: 8-10  Insulin depot in subcutaneous tissue Basal: 20 IU/day - 0,8 IU/h Basal: 20 IU/day - 0,8 IU/h  Electronic memory as a form of delivered insulin dose registration

 Basal insulin  Once or twice a day  Insulin dose adaptation once or twice per day  If injected, cannot be revoked  Basal function:  Insulin dose adaptation every hour or every half an hour  Possibility of suspension of basal insulin administration  Possibility of keeping different basal insulin profile in electronic memory – Basal Profiles  Possibility of adaptation of basal insulin for current needs - Temporary basal rate

 Bolus function: One shot of insulin (RI or analogue) before the meal One shot of insulin (RI or analogue) before the meal One meal – one shot of insulin One meal – one shot of insulin One kind of insulin shooting One kind of insulin shooting  Correction insulin: combine with meal insulin in one injection  Bolus function:  Three kinds of boluses:  Normal (for Carbohydrates)  Extended (for Fat-protein)  Multiwave (for Mixed)  Possibility of programming one meal bolus as a multi-bolus (before, during and after a meal)  Correction insulin: programmed separately

The schema of insulin dosing in FIIT Total daily dose 50% Meal insulin 15% lunch 20% dinner 50% Basal insulin 15% Breakfast

 Patient’s age  Diabetes duration ( years)  C-petid residual secretion  BMI  Concomitant disease and hormonal therapy The factors influence basal insulin dose

Patient’s age and duration of diabetes patients with T1DM on insulin pumps

The Percentage of basal insulin AgeAverageSD Preschooler Prepubertal Pubertal Danne T., Diabetologia, 2008 AgeAverageSD Preschooler Prepubertal Pubertal Pańkowska E.. Pediatric Diabetes, 2008

Duration of diabetes and C-peptide residual secretion C-peptide and percentage of basal insulin in TDD

The basal to bolus proportion related to C-peptide Pańkowska E., Pediatric Diabetes, 2008 * p<0,05 *

Basal insulin patterns

Basal insulin dose in children and adolescents preschooler 1-6 ys, 0, 2-0, 3j/g Prepubertal 7-12 ys, 0,4-0,5j/g pubertal, ys; 0,9-1,0 j/g

5years old girl with diabetes from 2 years. Basal insulin 6-10% of TDD 15 years old girl with diabetes from 10 ys Basal insulin 30-45%of TDD

Anna, 7 years old Diabetes for second year of life 5 years duration, c-peptide naive c-peptide naive Asthma bronchiale Hb1c- 6,5% ( average) Case report

Blood glucose and insulin applaying pl-insmadz.pdfpl-insmadz.pdf

Case report  14 years old boy,  Diabetes duration 4 years,  HbA1c 7,0%

The blood glucose profile and insulin applying Paweł.pdfPaweł.pdf Temporal basal rate and sick days

The optional boluses in insulin pump Normal bolusExtanded bolus Dual-wave bolus BASAL RATE IR x nCUIR x nFPU IR x nCU + IR x nFPU

 the proportion of basal to bolus insulin can be ranged from 10% to 60%  Meal daily plan are flexible in term of meal’s size, timing for breakfast, lunch and dinner and meal nutrients contains.  Dual wave boluses/multiwave are applied by patients in their daily care.  Basal rate is lower during a day than night hours, Summary

Tailoring insulin programming in pump therapy is one of the way in getting recommended metabolic control. Conclusion